Myriad Genetics
MYGN
#7306
Rank
ยฃ0.41 B
Marketcap
ยฃ4.42
Share price
-0.17%
Change (1 day)
34.19%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of March 2026 : ยฃ0.25 Billion

According to Myriad Genetics's latest financial reports the company has ยฃ0.25 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ0.27 B-51.09%
2024-12-31$ยฃ0.55 B-9.12%
2023-12-31$ยฃ0.61 B-16.04%
2022-12-31$ยฃ0.73 B2.12%
2021-12-31$ยฃ0.71 B
2020-06-30$ยฃ0.74 B-13.6%
2019-06-30$ยฃ0.85 B17.28%
2018-06-30$ยฃ0.73 B23.87%
2017-06-30$ยฃ0.59 B5.2%
2016-06-30$ยฃ0.56 B32.98%
2015-06-30$ยฃ0.42 B0.44%
2014-06-30$ยฃ0.42 B-12.3%
2013-06-30$ยฃ0.47 B18.27%
2012-06-30$ยฃ0.40 B14.72%
2011-06-30$ยฃ0.35 B-3.94%
2010-06-30$ยฃ0.36 B39.52%
2009-06-30$ยฃ0.26 B23.22%
2008-06-30$ยฃ0.21 B25.79%
2007-06-30$ยฃ0.17 B24.44%
2006-06-30$ยฃ0.13 B78.13%
2005-06-30$ยฃ76.69 M-19.43%
2004-06-30$ยฃ95.19 M-4.01%
2003-06-30$ยฃ99.16 M17.94%
2002-06-30$ยฃ84.08 M-14.73%
2001-06-30$ยฃ98.61 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Abbott Laboratories
ABT
ยฃ39.38 B 15,519.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
ยฃ1.79 B 611.63%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.64 B 1,741.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ0.21 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
ยฃ5.11 B 1,930.62%๐Ÿ‡บ๐Ÿ‡ธ USA